In summary, the IGFBP7 Risk Score (IGRS) provided a robust prognostic tool for astrocytomas by categorizing patients into High and Low IGRS groups, with High IGRS correlating with worse outcomes. The gene discussed is IGFBP7; the disease is astrocytoma (excluding glioblastoma).